
Number of publications published per year by Bedossa, Pierre. (Source : PubMed)

Distribution of publications types for Bedossa, Pierre. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis.
J. Hepatol.
2010

Harmony in liver fibrosis...
J. Hepatol.
2010;52;3
Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitis.
Clin. Gastroenterol. Hepatol.
2010;8;2
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4.
Gut
2009;58;12

[Sclerosing mesenteritis: can it be a IgG4 dysimmune disease?]
Ann Pathol
2009;29;6
A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.
Gastroenterology
2009;137;5

Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.
J. Med. Virol.
2009;81;9
Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status.
J. Hepatol.
2009;51;2

Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.
J. Hepatol.
2009;51;1

Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
Aliment. Pharmacol. Ther.
2009;30;1
[ See timeline ] [ See all publications ]
means that Bedossa, Pierre has 49 papers cited a least 49 times - methodology
Service d'Hépatologie, Hôpital Beaujon, AP-HP, INSERM U773-CRB3, Université Denis Diderot-Paris7, 100 Boulevard du Général Leclerc, 92110 Clichy, France.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.